UnitedHealth Group (NYSE:UNH) Shares Down 3.3% – Should You Sell?

Posted by Geri Gentry on Nov 5th, 2026

UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report)’s share price was down 3.3% on Thursday. The company traded as low as $394.08 and last traded at $395.7410. Approximately 6,856,144 shares changed hands during mid-day trading, a decline of 5% from the average daily volume of 7,241,529 shares. The stock had previously closed at $409.38.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: UnitedHealth’s third-quarter adjusted EPS of about $4.69 and revenue above $113 billion topped expectations. The results are bolstering confidence that margins may be recovering, though investors will want evidence that medical-cost pressure is easing sustainably. UnitedHealth Q3 earnings lift confidence in margin recovery
Positive Sentiment: The board declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a stated yield of 2.3%. The payment is scheduled for December 15 to shareholders of record December 7. UnitedHealth authorizes quarterly dividend
Positive Sentiment: Zacks highlighted UNH as a long-term momentum stock, which may support investor interest, although the article focuses on its rating framework rather than announcing a new company development. Why UnitedHealth is a top momentum stock for the long term
Neutral Sentiment: A possible shift toward cyclical stocks and expectations of political gridlock could put healthcare insurers, including UNH, in focus. The outlook depends on policy developments and investor sector preferences. Cyclical stocks and potential political shifts
Negative Sentiment: Senator Elizabeth Warren renewed calls for scrutiny of UnitedHealth’s growing reach following the Amedisys deal, while Mark Cuban warned that AI could disrupt large healthcare companies. These comments add regulatory and longer-term business-model uncertainty, but the articles do not report a new regulatory action. UnitedHealth faces breakup pressure and AI concerns

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on UNH shares. JPMorgan Chase & Co. upped their price target on shares of UnitedHealth Group from $516.00 to $524.00 and gave the company an “overweight” rating in a research report on Friday, October 16th. UBS Group reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. Royal Bank Of Canada raised their target price on UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a research note on Tuesday, October 20th. Jefferies Financial Group increased their price target on UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $450.00 price objective on shares of UnitedHealth Group in a research note on Thursday, October 15th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $463.93.

Get Our Latest Analysis on UNH

UnitedHealth Group Stock Down 3.3%

The company has a market cap of $355.21 billion, a P/E ratio of 22.60, a price-to-earnings-growth ratio of 1.46 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The stock has a fifty day moving average price of $390.73 and a two-hundred day moving average price of $363.43.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same period in the prior year, the firm posted $2.59 EPS. UnitedHealth Group’s quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.19% of the company’s stock.

Institutional Trading of UnitedHealth Group

Institutional investors and hedge funds have recently bought and sold shares of the company. General Partner Inc. acquired a new position in shares of UnitedHealth Group in the third quarter worth $512,000. PBCay One RSC Ltd acquired a new stake in shares of UnitedHealth Group in the first quarter valued at $14,343,000. Lee Johnson Capital Management LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at $6,180,000. Kinsale Capital Group Inc. grew its stake in UnitedHealth Group by 13.4% during the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock worth $16,006,000 after purchasing an additional 4,557 shares in the last quarter. Finally, Kelleher Financial Advisors increased its holdings in UnitedHealth Group by 135.9% during the 2nd quarter. Kelleher Financial Advisors now owns 5,495 shares of the healthcare conglomerate’s stock worth $2,284,000 after purchasing an additional 3,166 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.